Mechanisms of myocardial reperfusion injury

Annals of Thoracic Surgery

Volumn 68, Issue 5, 1999, Pages 1905-1912

  Park, James L ^a   Lucchesi, Benedict R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DEATH; COMPLEMENT ACTIVATION; CONFERENCE PAPER; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HUMAN; LEUKOCYTE ADHERENCE; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REPERFUSION INJURY;

ANIMALS; CELL SURVIVAL; COMPLEMENT ACTIVATION; HUMANS; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; NEUTROPHIL ACTIVATION; REACTIVE OXYGEN SPECIES; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0032730499     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(99)01073-5     Document Type: Conference Paper

References (25)

1. Jennings R.B., Sommers H.M., Smyth G.A., Flack H.A., Linn H. Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog. Pathology. 70:1960;68-78.
2. Hearse D.J., Humphrey S.M., Bullock G.R. The oxygen paradox and the calcium paradox two facets of the same problem? J Mol Cell Cardiol. 10:1978;641-668.
3. Rosenkranz E.R., Buckberg G.D. Myocardial protection during surgical coronary reperfusion. J Am Coll Cardiol. 1:1983;1235-1246.
4. Ganz W. Direct demonstration in dogs of the absence of lethal reperfusion injury. J Thrombos Thromboly. 4:1997;105-107.
5. Schaper W., Schaper J. Reperfusion injury an opinionated view . J Thrombos Thromboly. 4:1997;113-116.
6. Jolly S.R., Kane W.J., Bailie M.B., Abrams G.D., Lucchesi B.R. Canine myocardial reperfusion injury its reduction by the combined administration of superoxide dismutase and catalase . Circ Res. 54:1984;277-285.
7. Bolli R., Jeroudi M.O., Patel B.S., et al. Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion. Evidence that myocardial "stunning" is a manifestation of reperfusion injury. Circ Res. 65:1989;607-622.
8. Beard T., Carrie D., Boyer M.H., et al. Production of oxygen free radicals in myocardial infarction treated by thrombolysis. Arch Mal Coeur Vaiss. 87:1994;1289-1296.
9. Roberts M.J., Young I.S., Trouton T.G., et al. Transient release of lipid peroxides after coronary artery balloon angioplasty. Lancet. 336:1990;143-145.
10. Kim K.B., Chung H.H., Kim M.S., Rho J.R. Changes in the antioxidative defense system during open heart operations in humans. Ann Thorac Surg. 58:1994;170-175.
11. Uraizee A., Reimer K.A., Murry C.E. Failure of superoxide dismutase to limit size of myocardial infarction after 40 minutes of ischemia and 4 days of reperfusion in dogs. Circulation. 75:1987;1237-1248.
12. Gallagher K.P., Buda A.J., Pace D. Failure of superoxide dismutase and catalase to alter size of infarction in conscious dogs after 3 hours of occlusion followed by reperfusion. Circulation. 73:1986;1065-1076.
13. Hill J.H., Ward P.A. C3 leukotactic factors produced by a tissue protease. J Exp Med. 130:1969;505-518.
14. Yasojima K., Kilgore K.S., Washington R.A., Lucchesi B.R., McGeer P.L. Complement gene expression by rabbit heart upregulation by ischemia and reperfusion . Circ Res. 82:1998;1224-1230.
15. Yasojima K., Schwab C., McGeer E.G., McGeer P.L. Human heart generates complement proteins that are upregulated and activated after myocardial infarction. Circ Res. 83:1998;860-869.
16. Romson J.L., Hook B.G., Kunkel S.L., Abrams G.D., Schork M.A., Lucchesi B.R. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation. 67:1983;1016-1023.
17. Simpson P.J., Todd R.F. III, Fantone J.C., Mickelson J.K., Griffin J.D., Lucchesi B.R. Reduction of experimental myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion. J Clin Invest. 81:1988;624-629.
18. Kishimoto T.K., Rothlein R. Integrins, ICAMs, and selectins role and regulation of adhesion molecules in neutrophil recruitment to inflammatory sites . Adv Pharmacol. 25:1994;117-169.
19. Simpson P.J., Mickelson J., Fantone J.C., Gallagher K.P., Lucchesi B.R. Iloprost inhibits neutrophil function in vitro and in vivo and limits experimental infarct size in canine heart. Circ Res. 60:1987;666-673.
20. Amsterdam E.A., Stahl G.L., Pan H.L., Rendig S.V., Fletcher M.P., Longhurst J.C. Limitation of reperfusion injury by a monoclonal antibody to C5a during myocardial infarction in pigs. Am J Physiol. 268:1995;H448-H457.
21. Dreyer W.J., Michael L.H., Nguyen T., et al. Kinetics of C5a release in cardiac lymph of dogs experiencing coronary artery ischemia-reperfusion injury. Circ Res. 71:1992;1518-1524.
22. Mathey D., Schofer J., Schäfer H.J., et al. Early accumulation of the terminal complement complex in the ischemic myocardium after reperfusion. Eur Heart J. 15:1994;418-423.
23. Cruse J.M., Lewis R.E. Jr. Complement today. 1993;S. Karger AG, Basel.
24. Black S.C., Gralinski M.R., Friedrichs G.S., Kilgore K.S., Driscoll E.M., Lucchesi B.R. Cardioprotective effects of heparin or N-acetylheparin in an in vivo model of myocardial ischaemic and reperfusion injury. Cardiovasc Res. 29:1995;629-636.
25. Friedrichs G.S., Kilgore K.S., Manley P.J., Gralinski M.R., Lucchesi B.R. Effects of heparin and N-acetyl heparin on ischemia-reperfusion-induced alterations in myocardial function in the rabbit isolated heart. Circ Res. 75:1994;701-710.